Cooperative CAR targeting to selectively eliminate AML and minimize escape-Reference-Cited by-同舟云学术

Cooperative CAR targeting to selectively eliminate AML and minimize escape

Published:2023-11 Issue:11 Volume:41 Page:1871-1891.e6
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Haubner Sascha^ORCID,Mansilla-Soto Jorge,Nataraj Sarah,Kogel Friederike,Chang Qing,de Stanchina Elisa,Lopez Michael,Ng Mei Rosa,Fraser Kathryn,Subklewe Marion,Park Jae H.,Wang Xiuyan,Rivière Isabelle,Sadelain Michel^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference98 articles.

1. New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia;Mohty;Haematologica,2023

2. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma;Locke;N. Engl. J. Med.,2022

3. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N. Engl. J. Med.,2014

4. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia;Park;N. Engl. J. Med.,2018

5. Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma;Rodriguez-Otero;N. Engl. J. Med.,2023

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies;Blood;2024-09-12

2. T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting;Molecular Therapy;2024-09

3. Mapping the cancer surface proteome in search of target antigens for immunotherapy;Molecular Therapy;2024-09

4. Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T‐cell therapy in solid tumors;Cancer Science;2024-08-21

5. CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigations;Blood Advances;2024-08-16